Olfactory copy number association with age at onset of Alzheimer disease

Objectives: Copy number variants (CNVs) have been recognized as a source of genetic variation that contributes to disease phenotypes. Alzheimer disease (AD) has high heritability for occurrence and age at onset (AAO). We performed a cases-only genome-wide CNV association study for age at onset of AD. Methods: The discovery case series (n = 40 subjects with AD) was evaluated using array comparative genome hybridization (aCGH). A replication case series (n = 507 subjects with AD) was evaluated using Affymetrix array (n = 243) and multiplex ligation-dependent probe amplification (n = 264). Hazard models related onset age to CNV. Results: The discovery sample identified a chromosomal segment on 14q11.2 (19.3–19.5 Mb, NCBI build 36, UCSC hg18 March 2006) as a region of interest (genome-wide adjusted p = 0.032) for association with AAO of AD. This region encompasses a cluster of olfactory receptors. The replication sample confirmed the association (p = 0.035). The association was found for each APOE4 gene dosage (0, 1, and 2). Conclusion: High copy number in the olfactory receptor region on 14q11.2 is associated with younger age at onset of AD.

[1]  W. Chan,et al.  Changing Patient Characteristics and Survival Experience in an Alzheimer’s Center Patient Cohort , 2005, Dementia and Geriatric Cognitive Disorders.

[2]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[3]  Yong-shu He,et al.  [Structural variation in the human genome]. , 2009, Yi chuan = Hereditas.

[4]  T. Nakajima,et al.  HIV-1/AIDS susceptibility and copy number variation in CCL3L1, a gene encoding a natural ligand for HIV-1 co-receptor CCR5 , 2009, Cytogenetic and Genome Research.

[5]  Christoph Lange,et al.  Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.

[6]  Thomas W. Mühleisen,et al.  Large recurrent microdeletions associated with schizophrenia , 2008, Nature.

[7]  Kenneth G. C. Smith,et al.  Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake , 2008, The Journal of experimental medicine.

[8]  D. Zwijnenburg,et al.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.

[9]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[10]  K. Nave,et al.  Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A) , 2003, Nature Medicine.

[11]  J. Kaprio,et al.  Alzheimer's disease in Finnish twins , 1996, The Lancet.

[12]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[13]  Ronald Klein,et al.  Olfaction and the 5‐Year Incidence of Cognitive Impairment in an Epidemiological Study of Older Adults , 2008, Journal of the American Geriatrics Society.

[14]  R Brookmeyer,et al.  Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.

[15]  M. Kataki,et al.  A Method for Estimating Duration of Illness in Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[16]  H. Braak,et al.  Olfactory bulb changes in Alzheimer's disease , 2004, Acta Neuropathologica.

[17]  G. Schellenberg,et al.  Dementia and Alzheimer disease incidence: a prospective cohort study. , 2002, Archives of neurology.

[18]  R. Tanzi,et al.  Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses , 2008, Nature Reviews Neuroscience.

[19]  B. Trask,et al.  Extensive copy-number variation of the human olfactory receptor gene family. , 2008, American journal of human genetics.

[20]  P. Stankiewicz,et al.  Kabuki syndrome-like features associated with a small ring chromosome X and XIST gene expression. , 2001, American journal of medical genetics.

[21]  Steven A McCarroll,et al.  Extending genome-wide association studies to copy-number variation. , 2008, Human molecular genetics.

[22]  H Li,et al.  A general test of association for complex diseases with variable age of onset , 2000, Genetic epidemiology.

[23]  Matthew E Hurles,et al.  The population genetics of structural variation , 2007, Nature Genetics.

[24]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[25]  J. Gilbert,et al.  Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. , 2003, American journal of human genetics.

[26]  G. Schellenberg,et al.  Impaired olfaction as a marker for cognitive decline: Interaction with apolipoprotein E 4 status , 1999 .

[27]  E B Larson,et al.  Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. , 1999, Neurology.